(E)-4-(5-(2-(3-METHYLBENZYLIDENE)HYDRAZINYL)-2-(PYRIDIN-4-YL)PYRAZOLO[1,5-A]PYRIMIDIN-7-YL)MORPHOLINE, 95%, 2mg

1-[3,5-bis(trifluoromethyl)phenyl]-3-[(S)-[(1S,2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methyl]thiourea, 97, 1g

6-Methoxy-3-pyridinecarboxaldehyde>98.0%(GC)5g

4-AMINO-8-(2-FLUORO-6-METHOXYPHENYL)-N-PROPYLCINNOLINE-3-CARBOXAMIDE, 95%, 100mg

N-(5-(((5-(tert-Butyl)oxazol-2-yl)methyl)thio)thiazol-2-yl)piperidine-4-carboxamide, 99.0%, 5mg

2-(3-Amino-4-chlorobenzoyl)benzoic acid, 95.0%, 25g

3-(4-Bromo-1h-pyrazol-1-yl)benzaldehyde, 95%, 500mg

2-OXA-9-AZASPIRO[5.5]UNDECANE HCL, 95.0%, 100mg

5-Nitro-2-furaldehyde, 98.0%, 25g

3-Ethynylphenol, 95.0%, 5g

Single-channel microliter pipette Eppendorf Research® plus, 10 to 100 µl, yellow, 1 piece

Methyl 4-hydroxy-2-methoxybenzoate, 95.0%, 250mg

5-Bromo-2-(oxan-4-yl)pyrimidine, 98%, 50mg